Preview Mode Links will not work in preview mode

CorConsult Rx: Evidence-Based Medicine and Pharmacy

Oct 25, 2023

On this episode, we discuss the 5-HT1A receptor agonist, Exxua (gepirone). Exxua was recently FDA approved for the treatment of general depression. We review the long road this medication took to get approved. We also summarize the dosing, adverse effects, drug-drug interactions, etc for Exxua. 

Thanks for listening!


Oct 17, 2023

On this episode, we review the management of chronic kidney disease. We discuss when to use iron vs erythropoietin-stimulating agents (ESAs) for a patient with anemia due to their CKD.  We also go over the management of metabolic acidosis, hyperphosphatemia, secondary hyperparathyroidism, etc. 

Cole and I are happy to...

Oct 4, 2023

On this episode we discuss the management of benign prostatic hyperplasia (BPH) as well as overactive bladder (OAB). We review alpha blockers, 5-alpha-reductase inhihibitors, PDE5-inhibitors, anticholinergics, and beta 3 agonists. We close by discussing the best treatment options for patients with controlled BPH...